• Professional healthcare
  • Products & Services
  • Inspiration
  • Support & Contact
  • Shop
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
  • Consumer productsConsumer products
    • Home
    • Support
    • Product registration
    • My Philips
  • Healthcare professionalsHealthcare professionals
    • Home
    • Products
    • Services
    • Specialties
    • Solutions
  • Other business solutionsOther business solutions
    • Lighting
    • Automotive
    • Hearing solutions
    • More
    • Display solutions
    • Dictation Solutions
  • About usAbout us
    • Home
    • News
    • Investor Relations
    • Careers
    • More
    • Environmental, Social and Governance
    • Innovation
  • Contact and supportContact and support
    • Customer support
    • Professional healthcare support
    • Company contacts
  • Stay up-to-dateStay up-to-date
  • Select your country / languageGlobal / English
  • Privacy Notice
  • Terms of use
  • Cookie notice
  • Legal compliance
© Koninklijke Philips N.V., 2004 - 2025. All rights reserved.
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

CTG with maternal heart rate recording improves neonatal outcomes

  • By Philips
  • June 10 2025
  • 2 min read

A large study explored the safety of different cardiotocography (CTG) monitoring practices —methods of monitoring a fetus during labor — in clinical settings. It compared different fetal surveillance methods and their association with adverse short- and long-term fetal and neonatal outcomes.The study expanded upon existing reports suggesting that CTG monitoring of fetal heart rate (FHR) by an abdominal external ultrasound transducer without simultaneous maternal heart rate recording is associated with increased risk of early neonatal death and other asphyxia-related neonatal outcomes.

At-a-glance:

  • The study retrospectively examined nearly 214,000 full-term infants between 2005 and 2023.
  • FHR and maternal heart rate patterns were recorded by CTG during labor in the Hospital District of Helsinki and Uusimaa, Finland.
  • The study shows that CTG with simultaneous maternal heart rate registration is associated with improved neonatal outcomes.
Pregnant patient with FM30

Key take-aways from the study

Three methods were studied: The cohort was divided into three groups according to the method of CTG monitoring used at birth: women with an ultrasound transducer; women with both an ultrasound transducer and a maternal heart rate transducer using Philips solution; and women with an internal fetal scalp electrode.

There are drawbacks of just using external ultrasound transducer monitoring: The use of external fetal monitoring without simultaneous maternal heart rate monitoring increased the risk of neonatal complications.

There is increased independent risk of asphyxia-related neonatal outcomes for fetuses of mothers monitored during labor by external ultrasound transducer alone, compared with fetuses of mothers who also have maternal heart rate (MHR) recording or internal fetal scalp monitoring.

Education is needed: Clinicians and midwives should be aware of the effect of ultrasound transducer alone for fetal heart rate monitoring on potential adverse outcomes.

Clinical implications: “Our findings define that external FHR monitoring without a safeguard of simultaneous MHR recording is associated with increased risk of intrapartum fetal hypoxia, which can be detected as asphyxia-related fetal and neonatal outcomes at birth,” write the authors.

Intrapartum CTG with simultaneous maternal heart rate registration improves neonatal outcome

Download (PDF | 1.46 MB)
Copy this URLto share this story with your professional network
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.